Big generic drug approval bulletin today. If you have a family member or other loved who suffers from osteoporosis, the U.S. Food and Drug Administration has approved the first generic versions of the very popular Boniva (ibandronate) which treats and prevents post-menopausal osteoporosis.
According to the the National Institute for Health, osteoporosis is the thinning of bone tissue and loss of bone density over time. Osteoporosis is the most common type of bone disease. Researchers estimate that about 1 out of 5 American women over the age of 50 have osteoporosis. About half of all women over the age of 50 will have a fracture of the hip, wrist, or vertebra (bones of the spine).
Considering a thirty-day supply of brand-name Boniva is currently running almost $140, this could easily be a huge savings for many osteoporosis patients, so anyone with a family member or loved one on Boniva should ask their doctor if they are an appropriate candidate for one of the generic versions of Boniva.
- Finding Cheaper, More Affordable Boniva…. Somewhere
- Generic Drug News: FDA Approves First Generic Version of Zyprexa For Schizophrenia and Bipolar
- Generic Drug News: FDA Approves First Generic Version of Lexapro
- Quick Generic Drug News: FDA Approves Generic Version of Anti-Epileptic Drug Keppra XR
- Generic Drug Alert: FDA Approves Generic Version of Breast Cancer Drug Arimidex